3. Sun J, Zhang H, Song Z, et al. 2021; The negative impact of increasing age and underlying cirrhosis on the sensitivity of adenosine deaminase in the diagnosis of tuberculous peritonitis: a cross-sectional study in eastern China. Int J Infect Dis. 110:204–212. DOI:
10.1016/j.ijid.2021.07.061. PMID:
34332087.
Article
4. Sanai FM, Bzeizi KI. 2005; Systematic review: tuberculous peritonitis--presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther. 22:685–700. DOI:
10.1111/j.1365-2036.2005.02645.x. PMID:
16197489.
8. Shakil AO, Korula J, Kanel GC, Murray NG, Reynolds TB. 1996; Diagnostic features of tuberculous peritonitis in the absence and presence of chronic liver disease: a case control study. Am J Med. 100:179–185. DOI:
10.1016/S0002-9343(97)89456-9.
9. Talwani R, Horvath JA. 2000; Tuberculous peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: case report and review. Clin Infect Dis. 31:70–75. DOI:
10.1086/313919. PMID:
10913399.
Article
10. Aguado JM, Pons F, Casafont F, San Miguel G, Valle R. 1990; Tuberculous peritonitis: a study comparing cirrhotic and non-cirrhotic patients. J Clin Gastroenterol. 12:550–554. DOI:
10.1097/00004836-199010000-00013. PMID:
2146314.
13. Singh MM, Bhargava AN, Jain KP. 1969; Tuberculous peritonitis. An evaluation of pathogenetic mechanisms, diagnostic procedures and therapeutic measures. N Engl J Med. 281:1091–1094. DOI:
10.1056/NEJM196911132812003. PMID:
5824174.
14. Riquelme A, Calvo M, Salech F, et al. 2006; Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis: a meta-analysis. J Clin Gastroenterol. 40:705–710. DOI:
10.1097/00004836-200609000-00009. PMID:
16940883.
15. Lee JS, Kim KA, Lee WJ, et al. 2003; Diagnostic value of ascitic fluid adenosine deaminase activity for diagnosis of tuberculous peritonitis. Korean J Gastroenterol. 41:126–132.
16. Hillebrand DJ, Runyon BA, Yasmineh WG, Rynders GP. 1996; Ascitic fluid adenosine deaminase insensitivity in detecting tuberculous peritonitis in the United States. Hepatology. 24:1408–1412. DOI:
10.1002/hep.510240617. PMID:
8938171.
Article
17. Girón-González JA, Alvarez-Mon M, Menéndez-Caro JL, et al. 1994; T lymphocytes from alcoholic cirrhotic patients show normal interleukin-2 production but a defective proliferative response to polyclonal mitogens. Am J Gastroenterol. 89:767–773.
18. Dahale AS, Puri AS, Sachdeva S, et al. 2021; Reappraisal of the role of ascitic fluid adenosine deaminase for the diagnosis of peritoneal tuberculosis in cirrhosis. Korean J Gastroenterol. 78:168–176. DOI:
10.4166/kjg.2021.068. PMID:
34565786.
Article
19. Silva Dalsasso Joaquim L, Granzotto N, Dos Santos LF, Fontana Roman C, Martinello F. 2019; Analytical validation of an in-house method for adenosine deaminase determination. J Clin Lab Anal. 33:e22823. DOI:
10.1002/jcla.22823. PMID:
30489653. PMCID:
PMC6818597.
Article
20. Liao YJ, Wu CY, Lee SW, et al. 2012; Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis. World J Gastroenterol. 18:5260–5265.
21. Voigt MD, Kalvaria I, Trey C, Berman P, Lombard C, Kirsch RE. 1989; Diagnostic value of ascites adenosine deaminase in tuberculous peritonitis. Lancet. 1:751–754. DOI:
10.1016/S0140-6736(89)92574-9.
Article